| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 6,831 | 6,831 |
| Effect of exchange rates on cash | 139 | 285 |
| Net change in cash, cash equivalents, and restricted cash | -706 | 1,962 |
| Cash and cash equivalents at beginning of period | 9,764 | - |
| Cash and cash equivalents at end of period | 9,058 | - |
Cytosorbents Corp (CTSO)
Cytosorbents Corp (CTSO)